DENDRITIC CELLS & ACTINOBACILLUS ACTINOMYCETEMCOMITANS
DENDRITIC CELLS & ACTINOBACILLUS ACTINOMYCETEMCOMITANS
批准号:
6516355
负责人:
PAUL J EZZO
金额:
$11.59万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-03-01 至 2006-02-28
关键词:
Actinobacillus actinomycetemcomitans apoptosis bacteria infection mechanism bacterial toxins biopsy clinical research confocal scanning microscopy dendritic cells dental disorder chemotherapy dental disorder diagnosis enzyme linked immunosorbent assay gingiva helper T lymphocyte human subject human therapy evaluation immunofluorescence technique immunoregulation mixed tissue /cell culture monoclonal antibody morphometry patient oriented research periodontitis phenotype polymerase chain reaction stainings
中文摘要
描述:Ezzo博士的长期目标是建立一个成功的职业生涯,
学术牙科他近期的职业目标是进一步发展,
临床牙周领域的独立研究者,
research.贝勒牙科学院建立的研究环境
(BCD)克里斯托弗·卡特勒博士与雅克·班什罗博士合作
贝勒免疫学研究所(BIIR)的研究,将使Ezzo博士
在一个独特的科学/临床利基追求他的职业发展。
此外,Martha纳恩博士是一位生物统计学家,擅长设计和
临床试验分析师将共同指导艾佐医生卡特勒博士已经证实
由于共同的兴趣,与J. Banchereau博士合作
包括:1)不同树突状细胞的鉴定和表征
(DC)人组织中的亚群,2)DC对感染性疾病的影响,和3)
DC诱导抗感染保护性免疫的能力。在BCD和
BIIR,Ezzo博士80%以上的时间将用于
发展研究事业。一个系统的计划,包括课程
临床研究已经发展,以扩大知识博士Ezzo
在他的牙医/科学家奖培训中获得。无论是说教和
职业规划的研究阶段将使Ezzo博士能够扩展他的经验
临床研究和实现他的职业目标表征
DC和A之间的相互作用。actinomycetemcomitans(Aa)是一个逻辑上的"下一个
在Ezzo博士的职业生涯建设过程中的一步"。Ezzo博士的科学
背景技术涉及表征T细胞对Aa的应答,
有助于阐明DC在免疫应答中的重要性,
牙周病原体DC被称为"天然佐剂",这是由于
它们有效地引发初始T细胞的能力。他们的工作建立了
牙周组织是DC亚群的重要储存库。农村妇女在消除
对牙周病原体如Aa的免疫应答目前是未知的。
来自骨髓和淋巴前体的不同DC亚群能够
提供不同的细胞因子微环境,
Th2 T细胞发育。DC亚群在Aa感染期间引起,
因此,可能会对感染的结果产生深远的影响。的
假设LJP病变中引起的主要DC亚群是
对Aa及其白细胞毒素(lkt)的敏感性差异。Lkt优先
靶向骨髓细胞衍生的DC,其对其作用敏感。这些
亚群被消除,导致明显的Th1偏倚。炎性
反应过度导致牙周组织的不适当破坏
组织中这一假设将通过以下目标来解决:1)
原位表征之前在UP患者牙龈中发现的DC亚群
临床治疗后,2)从UP中分离和鉴定DC
患者,和3)进行DC表型和功能的体外研究,
与lkt + lkt-Aa共培养。
英文摘要
DESCRIPTION: Dr. Ezzo's long-term goal is to establish a successful career in
academic dentistry. His immediate career goal is to further his development as
an independent researcher in the area of clinically-oriented periodontal
research. The research environment established at Baylor College of Dentistry
(BCD) by Dr. Christopher Cutler, in collaboration with Dr. Jacques Banchereau
at the Baylor Institute for Immunological Research (BIIR), will enable Dr. Ezzo
to pursue his career development in a unique scientific/clinical niche.
Furthermore, Dr. Martha Nunn, a biostatistician with expertise in designing and
analyzing clinical trials, will co-mentor Dr. Ezzo. Dr. Cutler has established
a collaboration with Dr. J. Banchereau as a result of common interests
including: 1) identification and characterization of different dendritic cell
(DC) subsets in human tissues, 2) impact of DCs on infectious disease, and 3)
ability of DCs to induce protective immunity against infection. At BCD and
BIIR, greater than 80 percent of Dr. Ezzo's time will be appropriated for the
development of a research career. A systematic plan including courses in
clinical research has been developed in order to broaden the knowledge Dr. Ezzo
received in his Dentist/Scientist Award training. Both the didactic and
research phases of the career plan will allow Dr. Ezzo to expand his experience
in clinical research and to achieve his career goals. Characterizing the
interaction between the DC and A. actinomycetemcomitans (Aa) is a logical "next
step" in the process of career building for Dr. Ezzo. Dr. Ezzo's scientific
background involves characterizing the T cell response to Aa and will be
helpful in elucidating the importance of the DC in the immune response to this
periodontal pathogen. DCs have been referred to as "nature's adjuvant" due to
their ability to efficiently prime naive T cells. Their work has established
that the periodontium is a significant repository of DC subsets. Their role in
the immune response to periodontal pathogens, like Aa, is presently unknown.
Distinct DC subsets, derived from myeloid and lymphoid precursors, are capable
of providing different cytokine microenvironments that promote either Th1 or
Th2 T cell development. The DC subset elicited during an infection with Aa,
therefore, may have a profound effect on the outcome of infection. The
hypothesis is that the predominant DC subset elicited in LJP lesions is
differentially susceptible to Aa and its leukotoxin (lkt). Lkt preferentially
targets myeloid cell derived-DCs that bear sensitivity to its effects. These
subsets are eliminated, contributing to a pronounced Th1 bias. An inflammatory
response ensues resulting in the inappropriate destruction of periodontal
tissues. This hypothesis will be addressed by the following aims: 1) to
characterize in situ the DC subsets found in gingiva from UP patients before
and after clinical treatment, 2) to isolate and characterize DCs from UP
patients, and 3) to perform in vitro studies of DC phenotype and function after
co-culture with lkt+lkt-Aa.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DENDRITIC CELLS & ACTINOBACILLUS ACTINOMYCETEMCOMITANS
-
批准号:6634581
-
项目类别:
-
资助金额:$11.88万
-
财政年份:2001
-
负责人:PAUL J EZZO
-
依托单位:
DENDRITIC CELLS & ACTINOBACILLUS ACTINOMYCETEMCOMITANS
-
批准号:6721202
-
项目类别:
-
资助金额:$12.14万
-
财政年份:2001
-
负责人:PAUL J EZZO
-
依托单位:
DENDRITIC CELLS & ACTINOBACILLUS ACTINOMYCETEMCOMITANS
-
批准号:6228863
-
项目类别:
-
资助金额:$11.35万
-
财政年份:2001
-
负责人:PAUL J EZZO
-
依托单位:
T CELL RESPONSE TO AA IN MICE
-
批准号:6104530
-
项目类别:
-
资助金额:$1.14万
-
财政年份:1998
-
负责人:PAUL J EZZO
-
依托单位:
T CELL RESPONSE TO AA IN MICE
-
批准号:6238295
-
项目类别:
-
资助金额:$3.97万
-
财政年份:1997
-
负责人:PAUL J EZZO
-
依托单位:
PERIODONTICS AND MICROBIOLOGY
-
批准号:3775548
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:PAUL J EZZO
-
依托单位:
T CELL RESPONSE TO AA IN MICE
-
批准号:5210010
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:PAUL J EZZO
-
依托单位:--
T CELL RESPONSE TO AA IN MICE IMMUNIZED SUBCUTANEOUSLY OR ORALLY INFECTED
-
批准号:3732387
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:PAUL J EZZO
-
依托单位:
PERIODONTICS AND MICROBIOLOGY
-
批准号:3753431
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:PAUL J EZZO
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: